| (D-Tyr6,βPhe11,Phe13,Nle14)-Bombesin (6-14) (free acid) | C63H79N13O12 | 1210.40 | H-D-Tyr-Gln-Trp-Ala-Val-βPhe-His-Phe-Nle-OH Trifluoroacetate salt |
|
| Bombesin (8-14) | C38H57N11O7S | 812.01 | 55749-98-9 | H-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| Cyclo(-D-Phe-His-Trp-Ala-Val-Gly-His-Leu-Leu) | C54H72N14O9 | 1061.26 | 143578-65-8 | Cyclo(-D-Phe-His-Trp-Ala-Val-Gly-His-Leu-Leu) |
| A-VI-5 | C22H40N6O10 | 548.59 | 39194-96-2 | H-Val-Glu-Ser-Ser-Lys-OH Acetate salt |
| Angiotensin I-Converting Enzyme Substrate | C24H27N3O5 | 437.50 | 69677-91-4 | Bz-Phe-Ala-Pro-OH |
| BPP 5a | C30H41N7O7 | 611.70 | 30505-63-6 | Pyr-Lys-Trp-Ala-Pro-OH |
| BPP 9a, Teprotide, SQ20881 | C53H76N14O12 | 1101.27 | 35115-60-7 | Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH |
| Bradykinin Potentiator C | C51H77N11O13 | 1052.24 | 30953-20-9 | Pyr-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro-OH |
| H-Pro-Thr-His-Ile-Lys-Trp-Gly-Asp-OH | C44H64N12O12 | 953.07 | 117620-76-5 | H-Pro-Thr-His-Ile-Lys-Trp-Gly-Asp-OH |
| H-Val-Trp-OH | C16H21N3O3 | 303.36 | 24587-37-9 | H-Val-Trp-OH |
| Bradykinin BK, Kallidin I, Kallidin-9, BRS-640 |
C50H73N15O11 | 1060.22 | 6846-03-3 | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH |
| (1-Adamantaneacetyl-D-Arg0,Hyp3,β-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin | C68H99N19O14S2 | 1470.79 | 130942-96-0 | 1-Adamantaneacetyl-D-Arg-Arg-Pro-Hyp-Gly-β-(2-thienyl)-Ala-Ser-D-Phe-β-(2-thienyl)-Ala-Arg-OH |
| (D-Arg0,Hyp2·3,D-Phe7)-Bradykinin | C60H87N19O14 | 1298.47 | 111929-26-1 | H-D-Arg-Arg-Hyp-Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg-OH |
| (D-Arg0,Hyp3,D-Phe7)-Bradykinin | C60H87N19O13 | 1282.47 | 109333-26-8 | H-D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg-OH Trifluoroacetate salt |
| (D-Arg0,Hyp3,D-Phe7,Leu8)-Bradykinin | C57H89N19O13 | 1248.45 | 135701-67-6 | H-D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Leu-Arg-OH |
| (D-Arg0,Hyp3,β-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin, Hoe k86-4321, Ahtp-BK | C56H83N19O13S2 | 1294.53 | 103412-36-8 | H-D-Arg-Arg-Pro-Hyp-Gly-β-(2-thienyl)-Ala-Ser-D-Phe-β-(2-thienyl)-Ala-Arg-OH |
| (p-Chloro-Phe5·8)-Bradykinin | C50H71Cl2N15O11 | 1129.11 | 125229-63-2 | H-Arg-Pro-Pro-Gly-p-chloro-Phe-Ser-Pro-p-chloro-Phe-Arg-OH |
| (Des-Arg9)-Bradykinin | C44H61N11O10 | 904.04 | 15958-92-6 | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH Acetate salt |
| (Des-Arg9,Leu8)-Bradykinin | C41H63N11O10 | 870.02 | 64695-06-3 | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu-OH |
| (Hyp3)-Bradykinin | C50H73N15O12 | 1076.22 | 37642-65-2 | H-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg-OH Acetate salt |
| Lys-Bradykinin Kallidin |
C56H85N17O12 | 1188.40 | 342-10-9 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Acetate salt |
| Lys-Bradykinin-Ser-Val-Gln-Val-Ser | C77H121N23O20 | 1688.95 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Ser-Val-Gln-Val-Ser-OH | |
| Lys-(Ala3)-Bradykinin | C54H83N17O12 | 1162.36 | 103545-18-2 | H-Lys-Arg-Pro-Ala-Gly-Phe-Ser-Pro-Phe-Arg-OH Acetate salt |
| Lys-(Des-Arg9)-Bradykinin (Des-Arg10)-Kallidin |
C50H73N13O11 | 1032.21 | 71800-36-7 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH Trifluoroacetate salt |
| Lys-(Des-Arg9,Leu8)-Bradykinin (Des-Arg10,Leu9)-Kallidin |
C47H75N13O11 | 998.19 | 71800-37-8 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu-OH Trifluoroacetate salt |
| Lys-(Hyp3)-Bradykinin | C56H85N17O13 | 1204.40 | 113662-39-8 | H-Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg-OH |
| Lys-(Tyr8)-Bradykinin (Tyr9)-Kallidin |
C56H85N17O13 | 1204.40 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg-OH | |
| Lys-Lys-(Hyp3,β-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin | C62H95N19O14S2 | 1394.69 | 103412-40-4 | H-Lys-Lys-Arg-Pro-Hyp-Gly-β-(2-thienyl)-Ala-Ser-D-Phe-β-(2-thienyl)-Ala-Arg-OH |
| Mca-(Ala7,Lys(Dnp)9)-Bradykinin | C66H81N15O19 | 1388.46 | 323577-36-2 | Mca-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(Dnp)-OH Trifluoroacetate salt |
| (N-Me-D-Phe7)-Bradykinin | C55H77N15O11 | 1124.31 | 158873-14-4 | H-Arg-Pro-Pro-Gly-Phe-Ser-N-Me-D-Phe-Phe-Arg-OH |
